Teen girls make better health choices with intervention program

For two consecutive years, researchers examined measures of cardiovascular fitness and self-esteem in sophomore girls attending Trenton Central High School and found students are making better health choices with an intervention program. Low Density Lipoprotein levels — the unhealthy cholesterol — also decreased significantly. WHF Teen Esteem is a gender-specific approach to teen girls’ health and wellness and is meant to be a replacement for traditional gymnastics and health classes.

Teen girls make better health choices with intervention program

For two consecutive years, researchers examined measures of cardiovascular fitness and self-esteem in sophomore girls attending Trenton Central High School and found students are making better health choices with an intervention program. Low Density Lipoprotein levels — the unhealthy cholesterol — also decreased significantly. WHF Teen Esteem is a gender-specific approach to teen girls’ health and wellness and is meant to be a replacement for traditional gymnastics and health classes.

Pharmacy :: Bayer Outlines New Global R&D Structures

Bayer HealthCare announced today a structural realignment of its global pharmaceutical research and development organization. The company also outlined its future U.S. pharma site plan, and said that New Jersey will be home to its U.S. headquarters for pharmaceuticals. These moves follow Bayer?s acquisition of Schering AG, Germany in June 2006 and are part of the company?s plan to integrate its pharmaceutical operations with those of Schering AG and Berlex Inc. (the U.S. subsidiary of Schering AG).

Restless Legs Syndrome :: Boehringer Ingelheim?s pramipexole for the treatment of Restless Legs Syndrome RLS

Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has approved pramipexole, a non-ergot dopamine agonist, for the treatment of moderate to severe primary Restless Legs Syndrome (RLS).1 This is an important milestone for pramipexole (Mirapexin? / Sifrol? / Mirapex?), which was already approved throughout the European Union in April 2006 for this second indication.

WHO :: Bird flu expert Chan, new WHO head – China

Dr Margaret Chan of China was nominated by the Executive Board of the World Health Organization for the post of Director-General. The Director-General is WHO’s chief technical and administrative officer. Dr Chan is a well-known public figure because of her record of leadership in fighting disease first in Hong Kong, and more recently at WHO.

Venus :: Happy birthday, Venus Express!

One year after its launch on 9 November 2005 and a few months into its science phase, ESA’s Venus Express keeps working well and continues to gather lots of data about the hot and noxious atmosphere of the planet. Newly released images show additional details of the thick cloud deck that surrounds Venus.

Head Lice :: The LouseBuster kills

University of Utah biologists invented a chemical-free, hairdryer-like device — the LouseBuster — and conducted a study showing it eradicates head lice infestations on children by exterminating the eggs or “nits” and killing enough lice to prevent them from reproducing.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack